Inhibition of drug transporter breast cancer resistance protein has no effect on the pharmacokinetics of major active metabolites of ozanimod

被引：0
|
作者：
Zhang, P. [1 ]
Ghosh, A. [1 ]
Thomas, M. [1 ]
Wang, X. [1 ]
Palmisano, M. [1 ]
Tran, J. [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0343
引用
收藏
页码：285 / 285
页数：1
相关论文
共 50 条
  • [31] NFR2/ABC transporter axis in drug resistance of breast cancer cells
    Zinat Sargazi
    Yalda Yazdani
    Amir Tahavvori
    Hamed Rahmani Youshanlouei
    Vahid Alivirdiloo
    Elmira Aboutalebi Vand Beilankouhi
    Mohammad Valilo
    Molecular Biology Reports, 2023, 50 : 5407 - 5414
  • [32] NFR2/ABC transporter axis in drug resistance of breast cancer cells
    Sargazi, Zinat
    Yazdani, Yalda
    Tahavvori, Amir
    Youshanlouei, Hamed Rahmani
    Alivirdiloo, Vahid
    Beilankouhi, Elmira Aboutalebi Vand
    Valilo, Mohammad
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (06) : 5407 - 5414
  • [33] Solitary Inhibition of the Breast Cancer Resistance Protein Efflux Transporter Results in a Clinically Significant Drug-Drug Interaction with Rosuvastatin by Causing up to a 2-Fold Increase in Statin Exposure
    Elsby, Robert
    Martin, Paul
    Surry, Dominic
    Sharma, Pradeep
    Fenner, Katherine
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (03) : 398 - 408
  • [34] Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
    Natarajan, Karthika
    Xie, Yi
    Baer, Maria R.
    Ross, Douglas D.
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (08) : 1084 - 1103
  • [35] Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C
    Allen, JD
    van Loevezijn, A
    Lakhai, JM
    van der Valk, M
    van Tellingen, O
    Reid, G
    Schellens, JHM
    Koomen, GJ
    Schinkel, AH
    MOLECULAR CANCER THERAPEUTICS, 2002, 1 (06) : 417 - 425
  • [36] Effect of capsaicin on breast cancer resistance protein (BCRP/Abcg2) and pharmacokinetics of probe substrates in rats
    Chen, Fen
    Wang, Liu
    Zhai, Xuejia
    Wang, Nanxi
    Qin, Yanjie
    Zhu, Chaoran
    Wu, Sanlan
    Lu, Yongning
    XENOBIOTICA, 2022, 52 (02) : 209 - 217
  • [37] Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition
    Yoo, Hyeonji
    Kim, Yeonjin
    Kim, Jinseong
    Cho, Hanhee
    Kim, Kwangmeyung
    MOLECULES, 2024, 29 (17):
  • [38] Inhibition of Breast Cancer Resistance Protein and Multidrug Resistance Associated Protein 2 by Natural Compounds and Their Derivatives
    Sjostedt, Noora
    Holvikari, Kira
    Tammela, Paivi
    Kidron, Heidi
    MOLECULAR PHARMACEUTICS, 2017, 14 (01) : 135 - 146
  • [39] Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues
    Maliepaard, M
    Scheffer, GL
    Faneyte, IF
    van Gastelen, MA
    Pijnenborg, ACLM
    Schinkel, AH
    van de Vijver, MJ
    Scheper, RJ
    Schellens, JHM
    CANCER RESEARCH, 2001, 61 (08) : 3458 - 3464
  • [40] Interaction of probenecid with the Breast Cancer Resistance Protein transporter (BCRP/ABCG2)
    Merino, G.
    Real, R.
    Molina, A. J.
    Pulido, M. M.
    Prieto, J. G.
    Alvarez, A. L.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2006, 3 (04) : 236 - 241
12345